Senior Medical Science Liaison
CSL
Summary
The Medical Scientific Liaison is a primarily field-based health professional/scientist with both scientific and clinical expertise. They will successfully execute all critical medical affairs functions, which include the strategic medical plan for the US region, managing key thought-leader relationships, disseminating/presenting educational information on Seqirus portfolio of influenza vaccines, and answering questions from healthcare clinicians and disease experts regarding product safety or efficacy that is not addressed in a product's label.
Job description
The Medical Scientific Liaison will also play a key role in executing strategies to ensure medical professional societies and advocates have the information they need to make informed, data-driven vaccine recommendations. They will engage in stakeholder mapping and have a unique role contributing to the creation of targeted materials, medical education content, and engagement strategies within the US region.
Medical Science Liaison and External Network Development & Management (50%)
- Identify key opinion leaders in infectious disease and cultivate a network of influenza experts within a given geography for key areas of scope.
- Maintain excellent professional relationships with medical and public health experts, government officials, immunization advisory committees, partner companies. Accountable for engaging and cultivating relationships with leading KOLs to gain contribution/participation in advisory boards, greater understanding of influenza vaccines and insights into unmet patient needs and developing policy issues.
- Represents Seqirus at scientific and medical forums, including medical education forums, scientific roundtables, congresses, and symposia.
- Planning, designing and managing or participating in local, regional, national and global medical Advisory Boards including working with vendor(s) in support of medical affairs strategies.
Scientific Expertise and Scientific Communication (30%)
- Collaborate with the US Medical Director and MSL Lead on strategy and execution of medical communication plans and projects related to vaccine recommendations and policy
- Present data on product/disease area at internal and external meetings
- Contribute to the development/editing of medical-to-medical education content (in collaboration with US Medical director and MSL Lead) to include MSL field materials, FAQs, symposia, advisory board, and training content.
- Represent Medical Affairs at internal or external meetings, including serving as a Seqirus medical affairs representative at conferences
- Assist in execution and implementation of medical excellence initiatives, including summarizing and elevating field insights
- Serve as a medical resource on the disease area and product portfolio
- Maintain a high level of expertise on the disease area and relevant policy issues
Other job duties that may be assigned from time to time (20%)
- Execution of Educational Projects including gathering of metrics e.g., CME grants
- Facilitate US grant review and approval process (including IIRs)
- As a member of Regional Medical Affairs team, work together to ensure consistency and compliance in medical decision-making and systems and processes for Seqirus
- Develop and maintain knowledge of US and International pharmaceutical regulations, guidelines codes of practices and Seqirus policies related to all medical activities
Requirements
- Degree in nursing, pharmacy, or advanced degree in science/medicine (MD, PhD, PharmD) preferred
- 5+ years' relevant pharmaceutical/biopharmaceutical industry experience
- Prior experience providing MSL level support in specific therapeutic areas
- Domestic travel ~40%
Company overview
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. Founded in 1916 as Commonwealth Serum Laboratories, CSL has grown to become the world's fifth largest biotechnology company with operations in over 35 countries. The company specializes in blood plasma derivatives, vaccines, antivenoms, and cell culture reagents used in medical and genetic research applications. CSL operates through several key divisions including CSL Behring (focusing on rare and serious diseases), CSL Seqirus (one of the world's largest influenza vaccine providers), CSL Plasma, and CSL Vifor. With over 32,000 employees globally, CSL maintains a strong R&D pipeline and has invested over US$3.3 billion in research and development over the past five years. The company is publicly traded on the Australian Securities Exchange and has its global headquarters in Parkville, Melbourne, Australia.